We help keep patients, caregivers, and medical professionals informed about the latest happenings at the Brigham and Women’s Hospital Heart & Vascular Center through newsletters, press releases, our annual report, and other media. Below is a list of our recent heart and vascular news stories.
October 20, 2016 - Team Led by BWH Receives $75 million to Fight Heart Disease
Calum MacRae, MD, PhD, Chief, Division of Cardiovascular Medicine at BWH, and an international team of collaborators have been selected to receive the One Brave Idea Research Award, a five year, $75 million award from the American Heart Association, Verily Life Sciences and AstraZeneca.
May 5, 2016 - Why Are Women less likely to be Prescribed Statins than Men?
Study pinpoints identifies four factors that may account for sex differences in statin therapy among patients with coronary artery disease (CAD).
Jan 13, 2016 - Novel Blood Thinner Found To Be Safe and Effective in Women
Study shows cangrelor reduces the odds of cardiovascular events by 35 Percent in women undergoing coronary stenting when compared to standard therapy
Jan 12, 2016 - Triglycerides: the Next Big Lipid Target?
Researchers plan to conduct a large-scale study testing the impact of triglyceride reduction on cardiovascular event rates
Nov 30, 2015 - Air Pollution and Cardiovascular Disease: Increased Risk for Women with Diabetes
Nationwide study of women reveals that those with diabetes are most susceptible to the adverse cardiovascular risks posed by exposure to air pollution.
August 12, 2015 - Predicting Risk for Deadly Cardiac Events
A marker commonly used to determine if a patient is having a heart attack can also be used to identify stable patients at high risk for deadly cardiac events, according to a new study.
June 8, 2015 – No Increased Cardiovascular Risk Detected for New Diabetes Medication
Trial by BWH researchers is the first to report on the cardiovascular safety of widely prescribed glucose-lowering drug.
March 30, 2015 – Elusive Origin of Pulmonary Hypertension Uncovered
New insights into blood vessel metabolism may have major implications for diagnosis, treatment, and prevention.
March 15, 2015 – Evolocumab, a PCSK9 inhibitor, Reduces Cardiovascular Events
Patients who received the experimental therapy were half as likely to experience adverse cardiovascular outcomes as compared to those who received standard care.
March 14, 2015 – Longer Duration Anti-Platelet Therapy is Beneficial for Patients with History of Heart Attack
New research finds that ticagrelor use beyond one year reduces the risk of further cardiovascular events.